Civic Intelligence

International Partnership for Microbicides Inc

990 • Fiscal year 2022 • EIN 01-0741733

Jan 01, 2022 to Dec 31, 2022 • Filed on Feb 01, 2023

Organization ProfileWWW.IPMGLOBAL.ORG

View Organization Page

8405 Colesville Road 600Silver Spring, MD 20910

(301) 608-2221

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2022

Liabilities / Revenue

8th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Net Margin

10th percentile

-29%

Higher net margin than 10% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Top Officer Pay

98th percentile

$861,139

Higher top officer pay than 98% of similar nonprofits.

Top officer pay equals 8.6% of source-year revenue.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Asset Growth

1st percentile

-100%

Faster asset growth than 1% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Revenue Growth

7th percentile

-51%

Faster revenue growth than 7% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Down

$0

Down $16,214,079 (-100%) from 2021

Net Assets

Down

$0

Down $11,828,967 (-100%) from 2021

Liabilities

Down

$0

Down $4,385,112 (-100%) from 2021

Revenue And Expenses
Liabilities / Revenue8th percentileNet Margin10th percentile

Revenue

Down

$9,961,492

Down $10,259,131 (-51%) from 2021

Expenses

Down

$12,803,344

Down $7,098,113 (-36%) from 2021

Net Income

Down

-$2,841,852

Down $3,161,018 (-990%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth1st percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $81,520,037Liabilities 2010: $58,213,017Net Assets 2010: $23,307,0202010Assets 2011: $52,600,905Liabilities 2011: $31,502,185Net Assets 2011: $21,098,7202011Assets 2012: $41,958,199Liabilities 2012: $22,695,453Net Assets 2012: $19,262,7462012Assets 2013: $40,537,408Liabilities 2013: $23,421,275Net Assets 2013: $17,116,1332013Assets 2014: $28,873,020Liabilities 2014: $14,087,446Net Assets 2014: $14,785,5742014Assets 2015: $23,222,913Liabilities 2015: $10,179,304Net Assets 2015: $13,043,6092015Assets 2016: $20,060,195Liabilities 2016: $5,525,129Net Assets 2016: $14,535,0662016Assets 2017: $23,049,272Liabilities 2017: $9,788,866Net Assets 2017: $13,260,4062017Assets 2018: $24,838,200Liabilities 2018: $12,803,774Net Assets 2018: $12,034,4262018Assets 2019: $28,113,782Liabilities 2019: $15,676,294Net Assets 2019: $12,437,4882019Assets 2020: $23,470,693Liabilities 2020: $11,916,324Net Assets 2020: $11,554,3692020Assets 2021: $16,214,079Liabilities 2021: $4,385,112Net Assets 2021: $11,828,9672021Assets 2022: $0Liabilities 2022: $0Net Assets 2022: $02022

Highlighted filing

2022

Assets$0
Liabilities$0
Net Assets$0
Open 2022 Filing

Operations Trend

Revenue Growth7th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MExpenses 2010: $56,341,7012010Expenses 2011: $37,733,2382011Revenue 2012: $31,674,981Expenses 2012: $31,029,986Net Income 2012: $644,9952012Revenue 2013: $32,787,591Expenses 2013: $33,447,172Net Income 2013: -$659,5812013Revenue 2014: $31,552,023Expenses 2014: $32,244,291Net Income 2014: -$692,2682014Revenue 2015: $33,000,728Expenses 2015: $33,224,496Net Income 2015: -$223,7682015Revenue 2016: $35,971,802Expenses 2016: $33,779,041Net Income 2016: $2,192,7612016Revenue 2017: $35,724,324Expenses 2017: $36,807,047Net Income 2017: -$1,082,7232017Revenue 2018: $25,206,212Expenses 2018: $26,337,178Net Income 2018: -$1,130,9662018Revenue 2019: $25,249,274Expenses 2019: $24,773,576Net Income 2019: $475,6982019Revenue 2020: $20,164,784Expenses 2020: $20,752,154Net Income 2020: -$587,3702020Revenue 2021: $20,220,623Expenses 2021: $19,901,457Net Income 2021: $319,1662021Revenue 2022: $9,961,492Expenses 2022: $12,803,344Net Income 2022: -$2,841,8522022

Highlighted filing

2022

Revenue$9,961,492
Expenses$12,803,344
Net Income-$2,841,852
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Feb 1, 2023
Return Version
2022v4.1
Gross Receipts
$9,961,492
Mission and Program Overview

Mission

The international partnership for microbicides, inc. (ipm) was established in 2002 to accelerate the development and accessibility of microbicides to prevent the transmission of hiv. Its goal is to improve the efficiency to all efforts to deliver a safe and effective microbicide for women in developing countries as soon as possible.

To develop hiv prevention products and other sexual and reproductive health technologies for women, and to make them available and accessible where they are urgently needed.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$11,255,745$0▼ $11,255,745
Pledges and Grants Receivable$1,906,142$0▼ $1,906,142
Land, Buildings, and Equipment, Net$923,074$0▼ $923,074
Inventories for Sale or Use$721,130$0▼ $721,130
Accounts Receivable$531,162$0▼ $531,162
Prepaid Expenses and Deferred Charges$513,564$0▼ $513,564
Savings and Temporary Cash Investments$363,262$0▼ $363,262
Other Notes and Loans Receivable, Net-$0-
Receivable From Disqualified Prsn-$0-
Receivables From Officers Etc-$0-
Investments Other Securities-$0-
Investments Program Related-$0-
Investments in Publicly Traded Securities-$0-
Intangible Assets-$0-
Total Assets$16,214,079$0▼ $16,214,079
Other Assets Total-$0-
Liabilities
Accounts Payable and Accrued Expenses$2,854,197$0▼ $2,854,197
Deferred Revenue$1,126,246$0▼ $1,126,246
Other Liabilities$404,669$0▼ $404,669
Total Liabilities$4,385,112$0▼ $4,385,112
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$11,828,967$0▼ $11,828,967
Total Net Assets Fund Balance$11,828,967$0▼ $11,828,967
Total Liabilities and Net Assets / Fund Balance$16,214,079$0▼ $16,214,079
Compensation and Service Providers
Top Officer Pay98th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Zeda RosenbergFounder & CEO - Until 12/2022PT$536,261$324,878$861,139
Kathleen Flynn Evp ChiefFinancial Officer - Until 12/2022FT$341,231$216,175$557,406
Liza Folstein VpHuman Resources - Until 12/2022FT$290,618$195,355$485,973
Patricia Mayer-brennan EvpRegulatory Affairs - Until 06/2022FT$218,672$233,799$452,471
Brid Devlin Evp ProductDevelopment - Until 09/2022FT$339,321$60,153$399,474
Holly SeltzerVP, Communications - Until 06/2022FT$147,761$141,720$289,481
Jeremy Nuttall VpPreclinical Sci. - Until 09/2022FT$230,991$44,099$275,090
Patrick Spence Sr DirChem. & Anal. Sci. - Til 06/2022FT$145,218$109,208$254,426
Anita Garg Vp Strat Plan& Prog. Mgmt. - Until 09/2022FT$205,013$41,016$246,029

Board Members and Trustees

NameTitle
Alex CoutinhoDirector
Anja GiphartDirector
Florence HounDirector
Hilde Frafjord JohnsonDirector
Lillian MworekoDirector
Mark MitchnickDirector
Maureen LubaDirector
Pamela BarnesDirector
Tlaleng MofokengDirector

Highest Paid Contractors

ContractorServicesLocationCompensation
Sever Pharma SolutionsManufacturing1050 CINDY LANE, Carpinteria, CA 93013, Sw$3,301,160
Nusil Technology LLCManufacturing11921 ROCKVILLE PIKE SUITE 210, Rockville, MD 20852, Be$853,854
Ajinomoto Omnichem NvManufacturingPHARMACOLOGY BUILDING UNIVERSITY O, Bloemfontein, Sf$442,053
Osibeyond LLCIt Services-$357,338
Farmovs Parexel (pty) LtdBioequivalence Study-$240,282
Revenue and Support

Revenue Composition

Contributions and Grants
$9,915,456
Program Service Revenue
$0
Investment Income
$26,769
Other Revenue
$19,267
All Other Contributions
$39,901
Change in Net Assets
$-2,841,852
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$6,881,424
Other Expenses$5,921,920
Total Fundraising Expense$46,769
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$1,853,113$1,331,311-$3,184,424
Other Salaries and Wages$1,317,260$1,238,253-$2,555,513
Office Expenses$740,303$170,300$234$910,837
Insurance$123,177$371,822-$494,999
Other Employee Benefits$292,131$185,301-$477,432
Fees for Services Legal$198,433$201,828$1,535$401,796
Occupancy$263,256$90,127-$353,383
Pension Plan Contributions$233,956$119,118-$353,074
Payroll Taxes$196,663$114,318-$310,981
Fees for Services Accounting-$205,598-$205,598
Depreciation Depletion$33,988$101,422-$135,410
Other Expenses$67$31,733$45,000$31,800
Travel$26,591$4,436-$31,027
Conferences and Meetings$5,321$5,658-$10,979
Total Functional Expenses$7,927,024$4,829,551$46,769$12,803,344
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Receivables from Disqualified Persons-$0-
Receivables from Officers, Directors, Trustees, and Key Employees-$0-
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Draft version is made available electronically to the officers before submission to the irs.”

Form 990, Part VI, Section B, Line 12C

“Employees are required to complete a confidentiality agreement with the organization annually. The employee discloses any areas of potential conflict of interest and agrees to notify the appropriate individuals of any potential occurrences.”

Form 990, Part VI, Section B, Line 15

“The salary of the ceo is determined by referencing industry data to identify compensation level based on responsibilities, size of organization, and funding levels. Once the data is accumulated, the information is then presented to the finance chairperson and committee for review and approval of the board of directors. Upon approval, the approved salary is sent to the hr department by a member of the board of directors and/or coo for implementation. All chief level salaries are subject to the same procedures as the ceo salary review process. Compensation level recommendations are presented to the finance chairperson and committee for review and approval of the board of directors. Once the compensation levels have been approved, a member of the board of directors and/or ceo and/or coo submits these approvals to hr for implementation.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are made available to the public upon request. The financial statements are also part of the organization's annual report which is distributed to its donors and available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
International Partnership for
EIN
01-0741733
Phone
3016082221
Address
8405 COLESVILLE ROAD 600, SILVER SPRING, MD 20910

Signing Officer

Name
Kathleen Flynn
Title
CFO
Phone
3016082221
Signed
2023-02-01
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Kathleen Flynn
Formed
2002
Legal Domicile
Nc
Voting Board Members
9
Independent Board Members
9
Employees
33
Volunteers
10

Preparer

Firm
Marcum Llp
Address
1899 L STREET NW 850, WASHINGTON, DC 20036
Preparer
Aaron M Fox
Phone
2028225000
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 3

“Ipm transferred the program activities to population council on september 30, 2022.”

FORM 990, PART XI, LINE 9:

“Asset transfer -8,451,958. Foreign currency translation loss -30,158. Gain/loss on sale of assets -223,814. Sales and cogs -281,185.”

Raw XML AppendixShowing 400 of 860 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02854197
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt00
IRS990/AccountsReceivableGrp/BOYAmt0531162
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/AllOtherContributionsAmt039901
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0KATHLEEN FLYNN CFO
IRS990/BooksInCareOfDetail/PhoneNum03016082221
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt08405 COLESVILLE ROAD 600
IRS990/BooksInCareOfDetail/USAddress/CityNm0SILVER SPRING
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020910
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt011255745
IRS990/CashNonInterestBearingGrp/EOYAmt00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt013
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt01331311
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01853113
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt03184424
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt05658
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt05321
IRS990/ConferencesMeetingsGrp/TotalAmt010979
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt03301160
IRS990/ContractorCompensationGrp/CompensationAmt1853854
IRS990/ContractorCompensationGrp/CompensationAmt2442053
IRS990/ContractorCompensationGrp/CompensationAmt3357338
IRS990/ContractorCompensationGrp/CompensationAmt4240282
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt0BOX 590
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt1COOPPALLAAN 90
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt2PHARMACOLOGY BUILDING UNIVERSITY O
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0MALMO
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm1WETTERN
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm2BLOEMFONTEIN
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0SW
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd1BE
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd2SF
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd0SE-201 25
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd109230
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd209301
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01050 CINDY LANE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt111921 ROCKVILLE PIKE SUITE 210
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0CARPINTERIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1ROCKVILLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd093013
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd120852
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0SEVER PHARMA SOLUTIONS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1NUSIL TECHNOLOGY LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2AJINOMOTO OMNICHEM NV
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3OSIBEYOND LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4FARMOVS PAREXEL (PTY) LTD
IRS990/ContractorCompensationGrp/ServicesDesc0MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc1MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc2MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc3IT SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc4BIOEQUIVALENCE STUDY
IRS990/ContractTerminationInd0X
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt09915456
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt026769
IRS990/CYOtherExpensesAmt05921920
IRS990/CYOtherRevenueAmt019267
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-2841852
IRS990/CYSalariesCompEmpBnftPaidAmt06881424
IRS990/CYTotalExpensesAmt012803344
IRS990/CYTotalFundraisingExpenseAmt046769
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt09961492
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt01126246
IRS990/DeferredRevenueGrp/EOYAmt00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0101422
IRS990/DepreciationDepletionGrp/ProgramServicesAmt033988
IRS990/DepreciationDepletionGrp/TotalAmt0135410
IRS990/Desc0THE PRODUCT DEVELOPMENT (PD) DIVISION LED NON-CLINICAL, FORMULATION, MANUFACTURING, CHEMISTRY MANUFACTURING AND CONTROLS (CMC), ANALYTICAL, AND MATERIAL PLANNING AND SUPPLY ACTIVITIES FOR IPM'S PRODUCTS. THIS DIVISION REMAINED RESPONSIBLE FOR PRODUCT SUPPLY AND ASSOCIATED ACTIVITIES (INCLUDING PRODUCT MANUFACTURING, PACKAGING, LABELING, DISTRIBUTION, STABILITY) AS WELL AS THE POST-USE TESTING OF DAPIVIRINE RINGS TO SUPPORT ADHERENCE ASSESSMENTS DURING CLINICAL TRIALS. IN 2022, THE PD TEAM ALSO CONTINUED EFFORTS RELATED COMMERCIAL MANUFACTURING OF THE DVR. THIS INCLUDED COMPLETING CAPACITY PLANNING WITH CRITICAL VENDORS SUCH AS THE DVR PRODUCT MANUFACTURING PARTNER, DAPIVIRINE DRUG SUBSTANCE MANUFACTURING PARTNERS AND SILICONE MANUFACTURING PARTNER. ADDITIONALLY, PD SUPPORTED THE COMPLETION MANUFACTURING SCALE-UP (1X TO 5X) PROCESS VALIDATION. THE 5X PROCESS VALIDATION SUCCESSFULLY COMPLETED IN 2022 AND WILL BE USED AS THE DVR MANUFACTURING SCALE GOING FORWARD. FURTHER TO THIS, THE PD TEAM CONTINUED CMC, FORMULATION AND ANALYTICAL ACTIVITIES RELATED TO THE DEVELOPMENT THE THREE-MONTH DVR AND THE MPT RING. AS OF SEPTEMBER 30TH, 2022, THE PRODUCT DEVELOPMENT ACTIVITIES TRANSFERRED TO THE POPULATION COUNCIL AS PART OF IPM'S DISSOLUTION AND THE ASSOCIATED FUNDING AGREEMENT WITH THE POPULATION COUNCIL.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt033
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt04542294
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0205598
IRS990/FeesForServicesAccountingGrp/TotalAmt0205598
IRS990/FeesForServicesLegalGrp/FundraisingAmt01535
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0201828
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0198433
IRS990/FeesForServicesLegalGrp/TotalAmt0401796
IRS990/FinalReturnInd0X
IRS990/ForeignActivitiesInd00
IRS990/ForeignCountryCd0SF
IRS990/ForeignFinancialAccountInd01
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt032.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1740.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt051138
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1045515
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1139406
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1259410
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1358615
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1417436
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1543170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1634180
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1740693
IRS990/Form990PartVIISectionAGrp/PersonNm0ZEDA ROSENBERG
IRS990/Form990PartVIISectionAGrp/PersonNm1PAMELA BARNES
IRS990/Form990PartVIISectionAGrp/PersonNm2ALEX COUTINHO
IRS990/Form990PartVIISectionAGrp/PersonNm3ANJA GIPHART
IRS990/Form990PartVIISectionAGrp/PersonNm4FLORENCE HOUN
IRS990/Form990PartVIISectionAGrp/PersonNm5HILDE FRAFJORD JOHNSON
IRS990/Form990PartVIISectionAGrp/PersonNm6MAUREEN LUBA
IRS990/Form990PartVIISectionAGrp/PersonNm7MARK MITCHNICK
IRS990/Form990PartVIISectionAGrp/PersonNm8TLALENG MOFOKENG
IRS990/Form990PartVIISectionAGrp/PersonNm9LILLIAN MWOREKO
IRS990/Form990PartVIISectionAGrp/PersonNm10KATHLEEN FLYNN EVP CHIEF
IRS990/Form990PartVIISectionAGrp/PersonNm11PATRICIA MAYER-BRENNAN EVP
IRS990/Form990PartVIISectionAGrp/PersonNm12BRID DEVLIN EVP PRODUCT
IRS990/Form990PartVIISectionAGrp/PersonNm13LIZA FOLSTEIN VP
IRS990/Form990PartVIISectionAGrp/PersonNm14HOLLY SELTZER
IRS990/Form990PartVIISectionAGrp/PersonNm15JEREMY NUTTALL VP
IRS990/Form990PartVIISectionAGrp/PersonNm16PATRICK SPENCE SR DIR
IRS990/Form990PartVIISectionAGrp/PersonNm17ANITA GARG VP STRAT PLAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0810001
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10511891
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11413065
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12340064
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13427358
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14272045
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt15231920
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt16220246
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt17205336
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/TitleTxt0FOUNDER & CEO - UNTIL 12/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10FINANCIAL OFFICER - UNTIL 12/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt11REGULATORY AFFAIRS - UNTIL 06/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt12DEVELOPMENT - UNTIL 09/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt13HUMAN RESOURCES - UNTIL 12/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt14VP, COMMUNICATIONS - UNTIL 06/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt15PRECLINICAL SCI. - UNTIL 09/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt16CHEM. & ANAL. SCI. - TIL 06/2022
IRS990/Form990PartVIISectionAGrp/TitleTxt17& PROG. MGMT. - UNTIL 09/2022
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt09
IRS990/GovernmentGrantsAmt09875555
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt09961492
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt09
IRS990/IndivRcvdGreaterThan100KCnt031
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt0371822
IRS990/InsuranceGrp/ProgramServicesAmt0123177
IRS990/InsuranceGrp/TotalAmt0494999
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InventoriesForSaleOrUseGrp/BOYAmt0721130
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt026769
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt026769
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt00
IRS990/IRPDocumentCnt035
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt00
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0923074
IRS990/LandBldgEquipBasisNetGrp/EOYAmt00
IRS990/LandBldgEquipCostOrOtherBssAmt00
IRS990/LegalDomicileStateCd0NC
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt011828967
IRS990/NetAssetsOrFundBalancesEOYAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt011828967
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt090127
IRS990/OccupancyGrp/ProgramServicesAmt0263256
IRS990/OccupancyGrp/TotalAmt0353383
IRS990/OfficeExpensesGrp/FundraisingAmt0234
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0170300
IRS990/OfficeExpensesGrp/ProgramServicesAmt0740303
IRS990/OfficeExpensesGrp/TotalAmt0910837
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherChangesInNetAssetsAmt0-8987115
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt0185301
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0292131
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0477432
IRS990/OtherExpensesGrp/Desc0CONTR'TD PROGRAM SERV.
IRS990/OtherExpensesGrp/Desc1CONTRACT PERSONNEL
IRS990/OtherExpensesGrp/Desc2COMMUNICATIONS
IRS990/OtherExpensesGrp/Desc3OTHER EXPENSES
IRS990/OtherExpensesGrp/FundraisingAmt045000
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0620209
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt138117
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt231733
IRS990/OtherExpensesGrp/ProgramServicesAmt01725347
IRS990/OtherExpensesGrp/ProgramServicesAmt1880740
IRS990/OtherExpensesGrp/ProgramServicesAmt236678
IRS990/OtherExpensesGrp/ProgramServicesAmt367
IRS990/OtherExpensesGrp/TotalAmt01725347
IRS990/OtherExpensesGrp/TotalAmt11545949
IRS990/OtherExpensesGrp/TotalAmt274795
IRS990/OtherExpensesGrp/TotalAmt331800
IRS990/OtherLiabilitiesGrp/BOYAmt0404669
IRS990/OtherLiabilitiesGrp/EOYAmt00
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0MISCELLANEOUS INCOME
IRS990/OtherRevenueMiscGrp/ExclusionAmt019267
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt019267
IRS990/OtherRevenueTotalAmt019267
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt01238253
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt01317260
IRS990/OtherSalariesAndWagesGrp/TotalAmt02555513
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0114318
IRS990/PayrollTaxesGrp/ProgramServicesAmt0196663
IRS990/PayrollTaxesGrp/TotalAmt0310981
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt0119118
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0233956
IRS990/PensionPlanContributionsGrp/TotalAmt0353074
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt01906142
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0513564
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt00
IRS990/PrincipalOfficerNm0KATHLEEN FLYNN
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0THE REGULATORY AFFAIRS TEAM OVERSAW THE MONTHLY DVR REGULATORY PROCESS, PROVIDING LEADERSHIP IN DOSSIER PREPARATION, FILINGS AND POST-APPROVAL MAINTENANCE IN EUROPE, THE UNITED STATES, SOUTH AFRICA AND OTHER TARGET AFRICAN COUNTRIES, WHERE PREPARATIONS ARE ONGOING FOR DVR MARKET INTRODUCTION. IMPORTANTLY, IN 2022, THE REGULATORY AFFAIRS TEAM MANAGED ALL POST-AUTHORIZATION MEASURES RELATED TO THE EMA POSITIVE SCIENTIFIC OPINION OF THE MONTHLY DVR. THIS DIVISION ALSO SUPPORTS ALL REGULATORY EFFORTS FOR OTHER IPM PRODUCTS ON THE PRODUCT DEVELOPMENT PATHWAY; THIS SUPPORT INCLUDES SUBMISSION AND MAINTENANCE OF INVESTIGATIONAL NEW DRUG (IND) DOCUMENTATION AND CONDUCTING REGULATORY AGENCY INTERACTIONS RELATED TO NEW PROTOCOLS FOR UPCOMING CLINICAL TRIALS. IN PARTNERSHIP WITH THE REGULATORY AFFAIRS TEAM, THE QUALITY ASSURANCE (QA) TEAM ENSURES PRODUCT DEVELOPMENT AND CLINICAL STUDIES ARE CONDUCTED IN COMPLIANCE WITH ALL APPLICABLE DRUG AND SAFETY LAWS. AUDITS ARE CONDUCTED DURING THE CONDUCT OF CLINICAL TRIALS TO PROVIDE ASSURANCE OF PROTOCOL COMPLIANCE, AND COMPLIANCE WITH INTERNATIONAL CONFERENCE ON HARMONIZATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) GUIDELINES, GOOD CLINICAL PRACTICES (GCP), AND ALL APPLICABLE REGULATIONS. VENDOR AUDITS ARE ALSO CONDUCTED WHERE IPM'S CLINICAL, PRECLINICAL, OR CMC WORK IS BEING CONDUCTED. AS OF SEPTEMBER 30TH, 2022, THE REGULATORY AFFAIRS ACTIVITIES TRANSFERRED TO THE POPULATION COUNCIL AS PART OF IPM'S DISSOLUTION AND THE ASSOCIATED FUNDING AGREEMENT WITH THE POPULATION COUNCIL.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt01931196
IRS990/ProgSrvcAccomActy3Grp/Desc0PROGRAM SUPPORT & ACCESS: IN 2022, IPM CONTINUED TO BUILD AWARENESS GLOBALLY ABOUT MICROBICIDES AND CREATE A FAVORABLE ENVIRONMENT IN SUPPORT OF MICROBICIDE PRODUCT DEVELOPMENT AND INTRODUCTION. THIS IS ACHIEVED BY INFORMING, EDUCATING, AND BUILDING SUPPORT FOR IPM'S WORK THROUGH COMMUNICATION MATERIALS, ADVOCACY AND DIRECT STAKEHOLDER ENGAGEMENT. IN CONJUNCTION WITH THESE EFFORTS, IPM ALSO CONTINUED WORK TO ENSURE THAT THE DVR CAN QUICKLY REACH THE WOMEN IN DEVELOPING COUNTRIES, WHO FACE THE HIGHEST RISK OF HIV. THIS WORK INCLUDES PARTNERING WITH A GLOBAL NETWORK OF ORGANIZATIONS, INCLUDING GOVERNMENT, PHARMACEUTICAL, HEALTH SERVICES, CIVIL SOCIETY AND ACADEMIC SECTORS, TO STRATEGICALLY PLAN FOR AFFORDABLE ACCESS TO THE DAPIVIRINE RING. AS OF SEPTEMBER 30TH, 2022, THE PROGRAM SUPPORT & ACCESS ACTIVITIES TRANSFERRED TO THE POPULATION COUNCIL AS PART OF IPM'S DISSOLUTION AND THE ASSOCIATED FUNDING AGREEMENT WITH THE POPULATION COUNCIL.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt01121147
IRS990/ProgSrvcAccomActyOtherGrp/Desc0IPM'S CLINICAL AFFAIRS DEPARTMENT REMAINED RESPONSIBLE FOR QUALITY CONTROL AND COMPLIANCE, MEDICAL SAFETY, PHARMACOVIGILANCE, MEDICAL AFFAIRS, CLINICAL OPERATIONS, BIOMETRICS, PUBLIC AFFAIRS, COMMUNITY PUBLIC AFFAIRS AND SOCIO-BEHAVIORAL SCIENCES FOR THE CLINICAL TRIALS CONDUCTED ON IPM'S PRODUCTS. KEY ACTIVITIES IN 2022 INCLUDED:SUPPORT OF THE MONTHLY DAPIVIRINE VAGINAL RING (DVR) CLINICAL TRIALS. IPM WORKED WITH CLINICAL TRIAL PARTNER, THE UNITED STATES (US) NATIONAL INSTITUTES OF HEALTH (NIH)-FUNDED MICROBICIDE TRIALS NETWORK (MTN) ON THE FOLLOWING CLINICAL TRIALS OF THE DVR:O MTN-034 (REACH): A PHASE 2A CROSSOVER TRIAL EVALUATING THE SAFETY OF AND ADHERENCE TO A VAGINAL MATRIX RING CONTAINING DAPIVIRINE AND ORAL EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN AN ADOLESCENT AND YOUNG ADULT FEMALE POPULATIONO MTN-042 (DELIVER): PHASE 3B, RANDOMIZED, OPEN LABEL SAFETY TRIAL OF DAPIVIRINE VAGINAL RING (VR) AND ORAL TRUVADA USE IN PREGNANCYO MTN-043 (B-PROTECTED): PHASE 3B, OPEN-LABEL, SAFETY AND DRUG DETECTION STUDY OF DAPIVIRINE VAGINAL RING AND ORAL TRUVADA IN BREASTFEEDING MOTHER-INFANT PAIRSFURTHER TO THIS, THE CLINICAL AFFAIRS TEAM SUPPORTED THE REGULATORY AFFAIRS TEAM IN DEVELOPMENT AND COMPLETION OF THE CLINICAL MODULES AND POST-APPROVAL AMENDMENTS OF THE DVR DOSSIERS SUBMITTED TO REGULATORY AUTHORITIES. PREPARED FOR AND INITIATED THE CLINICAL BRIDGING TRIAL OF IPM'S THREE-MONTH DVR. BUILDING ON THE PROMISE OF IPM'S MONTHLY DAPIVIRINE RING, IPM DEVELOPED THE THREE-MONTH DVR, WHICH IS DESIGNED TO INCREASE CONVENIENCE AND REDUCE ANNUAL COSTS AS COMPARED TO THE MONTHLY DVR. THE CLINICAL AFFAIRS TEAM WORKED ACROSS DEPARTMENTS AND WITH EXTERNAL PARTNERS TO DEVELOP THE PROTOCOL FOR THE BRIDGING TRIAL AND COMPLETE ALL NECESSARY TRIAL PREPARATIONS. THE BRIDGING TRIAL (IPM 054) INITIATED IN Q3 2022.SUPPORTED PREPARATIONS AND INITIATION OF A PHASE I CLINICAL TRIALS OF THE DAPIVIRINE-CONTRACEPTIVE VAGINAL RING, A MULTIPURPOSE PREVENTION TECHNOLOGY (MPT). THE THREE-MONTH DAPIVIRINE-CONTRACEPTIVE RING IS DESIGNED TO PROVIDE SLOW AND SIMULTANEOUS RELEASE OF BOTH THE ANTIRETROVIRAL (ARV) DRUG DAPIVIRINE TO PREVENT HIV AND THE CONTRACEPTIVE HORMONE LEVONORGESTREL TO PREVENT UNINTENDED PREGNANCY. A SECOND PHASE I CLINICAL TRIAL OF THE REFORMULATED MPT RING (IPM 056/CCTN019B) WAS IN PLANNING STAGES THROUGHOUT 2022 AND INITIATED IN Q3 2022. THIS TRIAL WILL BE CONDUCTED BY THE EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD). AS OF SEPTEMBER 30TH, 2022, THE CLINICAL AFFAIRS ACTIVITIES TRANSFERRED TO THE POPULATION COUNCIL AS PART OF IPM'S DISSOLUTION AND THE ASSOCIATED FUNDING AGREEMENT WITH THE POPULATION COUNCIL.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0332387
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt020007666
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt023382
IRS990/PYOtherExpensesAmt011333754
IRS990/PYOtherRevenueAmt0189575
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0319166
IRS990/PYSalariesCompEmpBnftPaidAmt08567703
IRS990/PYTotalExpensesAmt019901457
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt020220623
IRS990/QuidProQuoContributionsInd00
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt0-2841852
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0363262
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt09915456
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt020007666
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt020127462

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$0
Liabilities
$0
Net assets
$0
Revenue
$9,961,492
Expenses
$12,803,344
Net income
-$2,841,852
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2022Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.00$9.96$12.8$2.84
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.2$4.39$11.8$20.2$19.9$0.32
2020Detailed filing. Detailed filing data is available for this year.$23.5$11.9$11.6$20.2$20.8$0.59
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$28.1$15.7$12.4$25.2$24.8$0.48
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$24.8$12.8$12.0$25.2$26.3$1.13
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$23.0$9.79$13.3$35.7$36.8$1.08
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$20.1$5.53$14.5$36.0$33.8$2.19
2015Import issue. A filing source exists for this year, but detailed import did not complete cleanly.$23.2$10.2$13.0$33.0$33.2$0.22
2014Detailed filing. Detailed filing data is available for this year.$28.9$14.1$14.8$31.6$32.2$0.69
2013Detailed filing. Detailed filing data is available for this year.$40.5$23.4$17.1$32.8$33.4$0.66
2012Summary only. Only limited summary data is available for this year.$42.0$22.7$19.3$31.7$31.0$0.64
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$52.6$31.5$21.1$37.7
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$81.5$58.2$23.3$56.3